News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biomics Biotech Closes 34 Million RMB B Round


8/27/2008 10:51:20 AM

August 26, 2008 -- Biomics Biotechnologies (Nantong) Co., a company focused on RNAi drug R&D, closed a Series B funding of 34 million RMB ($5 million) on July 31 2008. The financing follows the company’s $3.5 million Series A round of January 2007, according to Zero2IPO. The B round was led by Jiangsu Dinghong Venture Capital Co., Ltd., with Jiangsu Benefit Rise Group also participating. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES